We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA’s PRAC Revises Methods for Measuring Pharmacovigilance Impacts
EMA’s PRAC Revises Methods for Measuring Pharmacovigilance Impacts
The European Medicines Agency’s pharmacovigilance committee revised its methods for measuring the health outcomes of its major regulatory interventions, aiming to improve industry safety monitoring practices and find out which activities have been the most successful.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor